Acute rhabdomyolysis after gemfibrozil therapy in a pregnant patient complicated with acute pancreatitis and hypertriglycerdemia while receiving continuous veno-venous hemofiltration therapy

Tzung Hai Yen, Chiz Tzung Chang, Mai Szu Wu, Chiu Ching Huang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Gemfibrozil therapy alone can induce severe myopathy and rhabdomyolysis. This catastrophic complication had been frequently reported in renal failure patients. Dosage reduction is therefore compulsory in patients with compromised renal function, no matter which type of renal replacement therapy they receive. This study's patient clearly demonstrates that gemfibrozil can induce severe rhabdomyolysis, even in patients receiving CVVH, if the dosage is not properly adjusted.

Original languageEnglish
Pages (from-to)139-143
Number of pages5
JournalRenal Failure
Volume25
Issue number1
DOIs
Publication statusPublished - 2003
Externally publishedYes

Fingerprint

Gemfibrozil
Hemofiltration
Rhabdomyolysis
Pancreatitis
Renal Replacement Therapy
Muscular Diseases
Therapeutics
Renal Insufficiency
Kidney

Keywords

  • Acute renal failure
  • Continuous veno-venous hemofiltration
  • Gemfibrozil
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Nephrology

Cite this

Acute rhabdomyolysis after gemfibrozil therapy in a pregnant patient complicated with acute pancreatitis and hypertriglycerdemia while receiving continuous veno-venous hemofiltration therapy. / Yen, Tzung Hai; Chang, Chiz Tzung; Wu, Mai Szu; Huang, Chiu Ching.

In: Renal Failure, Vol. 25, No. 1, 2003, p. 139-143.

Research output: Contribution to journalArticle

@article{e017bb70af3645d08a908a587885b1e4,
title = "Acute rhabdomyolysis after gemfibrozil therapy in a pregnant patient complicated with acute pancreatitis and hypertriglycerdemia while receiving continuous veno-venous hemofiltration therapy",
abstract = "Gemfibrozil therapy alone can induce severe myopathy and rhabdomyolysis. This catastrophic complication had been frequently reported in renal failure patients. Dosage reduction is therefore compulsory in patients with compromised renal function, no matter which type of renal replacement therapy they receive. This study's patient clearly demonstrates that gemfibrozil can induce severe rhabdomyolysis, even in patients receiving CVVH, if the dosage is not properly adjusted.",
keywords = "Acute renal failure, Continuous veno-venous hemofiltration, Gemfibrozil, Rhabdomyolysis",
author = "Yen, {Tzung Hai} and Chang, {Chiz Tzung} and Wu, {Mai Szu} and Huang, {Chiu Ching}",
year = "2003",
doi = "10.1081/JDI-120017477",
language = "English",
volume = "25",
pages = "139--143",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Acute rhabdomyolysis after gemfibrozil therapy in a pregnant patient complicated with acute pancreatitis and hypertriglycerdemia while receiving continuous veno-venous hemofiltration therapy

AU - Yen, Tzung Hai

AU - Chang, Chiz Tzung

AU - Wu, Mai Szu

AU - Huang, Chiu Ching

PY - 2003

Y1 - 2003

N2 - Gemfibrozil therapy alone can induce severe myopathy and rhabdomyolysis. This catastrophic complication had been frequently reported in renal failure patients. Dosage reduction is therefore compulsory in patients with compromised renal function, no matter which type of renal replacement therapy they receive. This study's patient clearly demonstrates that gemfibrozil can induce severe rhabdomyolysis, even in patients receiving CVVH, if the dosage is not properly adjusted.

AB - Gemfibrozil therapy alone can induce severe myopathy and rhabdomyolysis. This catastrophic complication had been frequently reported in renal failure patients. Dosage reduction is therefore compulsory in patients with compromised renal function, no matter which type of renal replacement therapy they receive. This study's patient clearly demonstrates that gemfibrozil can induce severe rhabdomyolysis, even in patients receiving CVVH, if the dosage is not properly adjusted.

KW - Acute renal failure

KW - Continuous veno-venous hemofiltration

KW - Gemfibrozil

KW - Rhabdomyolysis

UR - http://www.scopus.com/inward/record.url?scp=0037280466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037280466&partnerID=8YFLogxK

U2 - 10.1081/JDI-120017477

DO - 10.1081/JDI-120017477

M3 - Article

C2 - 12617342

AN - SCOPUS:0037280466

VL - 25

SP - 139

EP - 143

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 1

ER -